Patents by Inventor Toufik Abache

Toufik Abache has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190388506
    Abstract: The invention relates to a complement factor H fragment for use in the treatment and/or prophylaxis of a disease involving neovascularization.
    Type: Application
    Filed: December 30, 2016
    Publication date: December 26, 2019
    Inventors: Virginie DINET, Frédéric MASCARELLI, Toufik ABACHE, Sylvie JORIEUX
  • Publication number: 20190338269
    Abstract: Disclosed is a protein that is a factor X variant including a mutated sequence of SEQ ID NO:1; at its N-terminus, the protein includes the signal peptide of sequence SEQ ID NO:7 and a propeptide that differs from the natural factor X propeptide.
    Type: Application
    Filed: May 5, 2017
    Publication date: November 7, 2019
    Inventors: Abdessatar Sami CHTOUROU, Jean-Luc PLANTIER, Toufik ABACHE
  • Publication number: 20170190753
    Abstract: The invention relates to a recombinant protein having factor H activity.
    Type: Application
    Filed: December 19, 2014
    Publication date: July 6, 2017
    Inventor: Toufik ABACHE
  • Publication number: 20160177286
    Abstract: The present invention relates to a protein consisting of the sequence SEQ ID No.: 11 or 25 or 26, directly bound, or bound via a linker, especially -Arg-Lys-Arg-, to the sequence SEQ ID No.: 6.
    Type: Application
    Filed: June 20, 2014
    Publication date: June 23, 2016
    Applicants: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS, UNIVERSITE GRENOBLE I JOSEPH FOURIER
    Inventors: Aline Thomas, Marie-Claire Dagher, Raphael Marlu, Benoit Polack, Jean-Luc Plantier, Alexandre Fontayne, Toufik Abache
  • Publication number: 20140271603
    Abstract: A human cell line for implementing a method for preparing recombinant human factor H, more particularly the recombinant human factor H represented by the sequence SEQ ID NO: 1, or a variant possessing a percentage homology of at least 99% with the sequence SEQ ID NO: 1, with a yield greater than the quantity of endogenous factor H produced by said cell line.
    Type: Application
    Filed: October 25, 2012
    Publication date: September 18, 2014
    Inventor: Toufik Abache